Monitoring and treatment of minimal residual cancer of the prostate.
Mathé
G
G
Schally
A V
AV
Comaru-Schally
A M
AM
Mauvernay
R Y
RY
Vovan
M L
ML
Machover
D
D
Misset
J L
JL
Court
B
B
Bouchard
P
P
Duchier
J
J
D000230:Adenocarcinoma / Q000175:diagnosis* / Q000628:therapy; D000469:Alkaline Phosphatase / Q000032:analysis; D014408:Biomarkers, Tumor / Q000032:analysis; D003131:Combined Modality Therapy; D005500:Follow-Up Studies; D006801:Humans; D008055:Lipids / Q000032:analysis; D008297:Male; D019158:N-Acetylneuraminic Acid; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000628:therapy; D012794:Sialic Acids / Q000032:analysis
D014408:Biomarkers, Tumor; D008055:Lipids; D012794:Sialic Acids; C054080:lipid-associated sialic acid; D000469:Alkaline Phosphatase; D019158:N-Acetylneuraminic Acid